Tous Actualités
Suivre
Abonner TRB Chemedica International S.A.

TRB Chemedica International S.A.

Paris court will rule on the distribution rights for Gilead products in Switzerland

Geneva (ots)

TRB Chemedica International S.A. has issued legal
proceedings against Gilead Science Limited in a dispute over the
distribution rights of their products Viread™, Hepsera™, Truvada™ and
Emtriva™ for Switzerland.
TRB Chemedica International S.A., a small, family-owned Swiss
pharmaceutical company based in Geneva, was granted exclusive rights
by Gilead in 2003 to hold the regulatory approvals with related
reimbursements and to distribute their products in Switzerland.
Through substantial investment in scientific support and promotion
and an efficient distribution structure, TRB Chemedica International
S.A. achieved sales of SFr. 25 million in 2006.
In addition, TRB Chemedica International S.A. became the top
performer among all of Gilead's European distributors.
In 2006, Gilead incorporated a subsidiary in Switzerland, and
announced their intention to early terminate the distribution
agreements with TRB Chemedica International S.A. which were
contracted to end on 31 December 2010. TRB Chemedica International
S.A. disputed this position, expressing the view that such an early
termination would be unlawful.
However, Gilead terminated the distribution agreements in June
2007 for the end of 2007.
As a consequence, TRB Chemedica International S.A. will lose a
substantial part of its turnover and be obliged to lay off staff,
something that has never happened during the 25 years of the
company's existence.
TRB Chemedica International S.A. has now applied to the competent
court in Paris, France to rule on the unlawful early termination of
the agreements by Gilead and to compensate TRB Chemedica
International S.A. for the damage caused estimated at SFr. 12
million.

Contact:

G. G. Novelli
Director International Corporate Affairs
TRB Chemedica International S.A.
12 rue Michel-Servet
CH - 1211 Geneva 12.
E-Mail: giuseppe.novelli@trbchemedica.com
Tel.: +41/22/703'49'20 (Dir.)
Fax: +41/22/703'49'01